Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 36(36): 5134-5144, 2017 09 07.
Article in English | MEDLINE | ID: mdl-28481875

ABSTRACT

Toll-like receptors (TLRs) are key regulators of innate immune responses, and their dysregulation is observed in numerous inflammation-associated malignancies, including gastric cancer (GC). However, the identity of specific TLRs and their molecular targets which promote the pathogenesis of human GC is ill-defined. Here, we sought to determine the clinical utility of TLR2 in human GC. TLR2 mRNA and protein expression levels were elevated in >50% of GC patient tumors across multiple ethnicities. TLR2 was also widely expressed among human GC cell lines, and DNA microarray-based expression profiling demonstrated that the TLR2-induced growth responsiveness of human GC cells corresponded with the up-regulation of six anti-apoptotic (BCL2A1, BCL2, BIRC3, CFLAR, IER3, TNFAIP3) and down-regulation of two tumor suppressor (PDCD4, TP53INP1) genes. The TLR2-mediated regulation of these anti-apoptotic and tumor suppressor genes was also supported by their increased and reduced expression, respectively, in two independent genetic GC mouse models (gp130F/F and Gan) characterized by high tumor TLR2 expression. Notably, enrichment of this TLR2-regulated gene signature also positively correlated with augmented TLR2 expression in human GC tumors, and served as an indicator of poor patient survival. Furthermore, treatment of gp130F/F and cell line-derived xenograft (MKN1) GC mouse models with a humanized anti-TLR2 antibody suppressed gastric tumor growth, which was coincident with alterations to the TLR2-driven gene signature. Collectively, our study demonstrates that in the majority of GC patients, elevated TLR2 expression is associated with a growth-potentiating gene signature which predicts poor patient outcomes, thus supporting TLR2 as a promising therapeutic target in GC.


Subject(s)
Biomarkers, Tumor/metabolism , Cell Proliferation , Gene Expression Profiling , Stomach Neoplasms/pathology , Toll-Like Receptor 2/metabolism , Animals , Apoptosis , Biomarkers, Tumor/genetics , Female , Humans , Mice , Mice, Inbred NOD , Neoplasm Invasiveness , Neoplasm Staging , Prognosis , Stomach Neoplasms/genetics , Stomach Neoplasms/metabolism , Survival Rate , Toll-Like Receptor 2/genetics , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
2.
Oncogenesis ; 5: e216, 2016 Apr 04.
Article in English | MEDLINE | ID: mdl-27043662

ABSTRACT

Inhibitor of apoptosis proteins (IAPs) antagonize caspase activation and regulate death receptor signaling cascades. LCL-161 is a small molecule second mitochondrial activator of caspase (SMAC) mimetic, which both disengages IAPs from caspases and induces proteasomal degradation of cIAP-1 and -2, resulting in altered signaling through the NFκB pathway, enhanced TNF production and sensitization to apoptosis mediated by the extrinsic pathway. SMAC mimetics are undergoing clinical evaluation in a range of hematological malignancies. Burkitt-like lymphomas are hallmarked by a low apoptotic threshold, conveying sensitivity to a range of apoptosis-inducing stimuli. While evaluating LCL-161 in the Eµ-Myc model of aggressive Burkitt-like lymphoma, we noted unexpected resistance to apoptosis induction despite 'on-target' IAP degradation and NFκB activation. Moreover, LCL-161 treatment of lymphoma-bearing mice resulted in apparent disease acceleration concurrent to augmented inflammatory cytokine-release in the same animals. Indiscriminate exposure of lymphoma patients to SMAC mimetics may therefore be detrimental due to both unanticipated prolymphoma effects and increased susceptibility to endotoxic shock.

3.
South Med J ; 93(10): 982-5, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11147481

ABSTRACT

BACKGROUND: This study examined the factors that influenced African American women to select medicine as a career and their satisfaction with their career choice. METHODS: Of 132 African American female physicians in South Carolina, 62 responded to a survey of open-ended questions about why they chose medicine, what they liked and disliked about their career, and who influenced their decision to become a physician. RESULTS: The majority chose medicine for altruistic reasons and found that medicine provided challenge and the opportunity to make a positive difference. Family members, teachers, and physicians served as the common external influences in their decision to become a physician. Managed care, paper work, and time demands constituted the most disliked aspects of medicine. CONCLUSION: Altruistic reasons and/or an interest in science motivated most of these African American female physicians to study medicine. Family members most often were their principal role models.


Subject(s)
Black or African American/psychology , Career Choice , Job Satisfaction , Physicians, Women/psychology , Black or African American/statistics & numerical data , Attitude of Health Personnel , Data Collection , Female , Humans , Motivation , Physicians, Women/statistics & numerical data , South Carolina
SELECTION OF CITATIONS
SEARCH DETAIL
...